IL10 and inflammatory bowel disease: Notably, pretreatment with Os-EVs reversed this trend by reducing secretion of IL-1β, IL-6, as well as TNF-α, and enhancing IL-10 production, further supporting that Os-EVs have an anti-inflammatory repair effect on IBD in DSS-induced mice.